Improvement of selective serotonin reuptake inhibitor-induced sexual dysfunction without worsening of depressive symptom after switching to milnacipran

Clinical Neuropharmacology

Volumn 32, Issue 3, 2009, Pages 177-178

  Takahashi, Hitoshi ^a   Ishigooka, Jun ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Milnacipran; Sexual dysfunction; SNRI; SSRI

Indexed keywords

MILNACIPRAN; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADULT; ANOREXIA; CASE REPORT; DEPRESSION; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EJACULATION DISORDER; FOLLOW UP; HUMAN; LETTER; LIBIDO; MAJOR DEPRESSION; MALE; MENTAL CONCENTRATION; MONOTHERAPY; ORGASM DISORDER; PRIORITY JOURNAL; REMISSION; SEXUAL DYSFUNCTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; CYCLOPROPANES; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 67651172950     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181906752     Document Type: Letter

References (3)

1. Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand 2006;114:384-397.
2. Stahl SM, Grady MM, Moret C, et al. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 2005;10:732-747. (Pubitemid 41443048)
3. Baldwin D, Moreno RA, Briley M. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran. Hum Psychopharmacol 2008;23:527-532.